Weizhu Wu

机构：Chongqing University, Ningbo Medical Center Lihuili Hospital · ORCID：0000-0001-8285-3717

发表论文 11 篇 · 总被引 58 次 · h-index 4

代表论文

• Naples Prognostic Score: A Novel Predictor of Survival in Patients with Triple-Negative Breast Cancer (2024 · Journal of Inflammation Research · 被引 20)
• Exosomal lncRNA SNHG12 promotes angiogenesis and breast cancer progression (2024 · Breast Cancer · 被引 19)
• AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China (2024 · European journal of medical research · 被引 6)
• Risk factors and prediction of postoperative hypoparathyroidism among patients with papillary thyroid carcinoma (2019 · Translational Cancer Research · 被引 5)
• Gpx1 induces M2 polarization of macrophages, contributing to doxorubicin resistance in triple-negative breast cancer (2025 · Human Immunology · 被引 2)
• [Retracted] Molecular Mechanism of Secondary Endocrine Resistance in Luminal Breast Cancer (2021 · BioMed Research International · 被引 2)